This year's theme: Innovation and Patient Access After the Inflation Reduction Act
The Inflation Reduction Act (IRA) of 2022 brought a tremendous change in the Medicare Part D Prescription Drug benefit operation and coverage. The Academia and the industry has been analyzing the impact of the IRA on the Bio Pharmaceutical R&D, Access to drugs by the elderly population in the USA, impact on drugs approvals, and employment. This will have a spillover effect on the prescription drugs in the private market. The symposium will bring together industry experts, academia and the patients advocacy groups to discuss in front of our students, and faculty, and give them an opportunity to interact with the experts in the form of Q&A session. The symposium is open to all students, faculty, and the industry executives. It is a free event.
Agenda
| TIME | TOPIC |
| 8:30 - 9:00 AM | Registration & Networking Breakfast |
| 9:00 - 9:10 AM | Introduction Mahmud Hassan |
| 9:10 - 9:20 AM | Welcome Address Lei Lei, Ph.D. |
| 9:20 - 9:30 AM | Remarks Michael Lerner, JD |
| 9:30 - 9:40 AM | Life and Legacy of Irwin Lerner Ken Berkowitz |
9:40 - 10:05 AM Q&A 10:05 - 10:35 AM | Keynote Paul Hastings |
| 10:35 - 10:50 AM | Break |
10:50 - 11:50 AM Q&A 11:50 - 12:20 PM | Innovation and Patient Access After the Inflation Reduction Act Panel Moderator Panel Members John M. O'Brien, PharmD, MPH Patricia J. Goldsmith Amadou Diarra Ph.D |
| 12:20 - 1:20 PM | Networking Luncheon |
Contact
If you have any further questions, please contact Mahmud Hassan at hassanm@business.rutgers.edu.
Price
This event is free.